CONSHOHOCKEN, Pa., April 07, 2026--(BUSINESS WIRE)--PharmaForce, a leader in modern 340B program management, today announced the appointment of Lynn Eschenbacher, PharmD, MBA, FASHP, as Chief Pharmacy ...

READING, Pa.--(BUSINESS WIRE)--SAI MedPartners (“SAI”), a leading consultancy providing strategic insights and analytics to the pharmaceutical, biotechnology, and medical device industries, is pleased ...

"Approaching Compensation and Information to Sales Ops" is scheduled for Tuesday, September 19 at 3:00 p.m. CDT. Collecting data is one thing, knowing how to use it to improve business outcomes is ...

COLUMBUS, Ohio, July 31 PharmaForce, Inc., announced today that it has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for ...

READING, Pa., Sept. 29, 2022 /PRNewswire/ -- PharmaForce International (PFI) recently published competitive intelligence reports that benchmark the commercial operations and marketing expenditures of ...

READING, Pa., July 1, 2021 /PRNewswire/ — PharmaForce International (PFI) recently published a benchmarking report that profiles over forty of the leading Oncology Sales and Marketing organizations in ...

READING, Pa., Dec. 24, 2019 /PRNewswire/ -- PharmaForce International recently released two separate reports that focus on the benchmarking of biosimilar sales and marketing organizations in France, ...

PharmaForce International (PFI) is a competitive intelligence firm with over two decades of experience in the pharmaceutical and biotech industries. PFI has become the market leader in commercial ...

PharmaForce, a leader in modern 340B program management, today announced the appointment of Lynn Eschenbacher, PharmD, MBA, FASHP, as Chief Pharmacy and Strategy Officer, reinforcing its commitment to ...